StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by aldube30on Sep 29, 2016 4:51pm

106 Views

Post# 25292465

RE:RE:RE:RE:RE:RE:RE:RE:RE:Last month

Exactly, they need to see a proven use of day trading. Only few trades a day/week isn't enough to get the fisc on your back.

thepbay wrote: yes, it is to eliminate higher frequency traders. It is a very gray area, but I have heard stories. They come down on you if they see a pattern, that is all. GL

pbay

aldube30 wrote: You know nothing. The only situation where they'll audit someone and judge that the use of his TFSA is for day trading is when someone do 10-15 trades a day, not less.